S&P 500   4,561.76 (-0.13%)
DOW   35,972.66 (+0.06%)
QQQ   387.18 (-0.42%)
AAPL   190.27 (+0.17%)
MSFT   372.29 (-1.75%)
META   321.18 (-1.82%)
GOOGL   130.86 (-1.26%)
AMZN   146.09 (+0.00%)
TSLA   234.28 (-2.42%)
NVDA   465.42 (-0.49%)
NIO   7.07 (-2.75%)
BABA   72.90 (-2.64%)
AMD   119.44 (-1.42%)
T   16.68 (+0.66%)
F   10.44 (+1.75%)
MU   76.03 (-0.12%)
CGC   0.56 (+0.34%)
GE   122.89 (+0.89%)
DIS   92.22 (-0.51%)
AMC   6.80 (+2.26%)
PFE   28.99 (-4.86%)
PYPL   58.28 (+1.16%)
XOM   103.69 (+0.92%)
S&P 500   4,561.76 (-0.13%)
DOW   35,972.66 (+0.06%)
QQQ   387.18 (-0.42%)
AAPL   190.27 (+0.17%)
MSFT   372.29 (-1.75%)
META   321.18 (-1.82%)
GOOGL   130.86 (-1.26%)
AMZN   146.09 (+0.00%)
TSLA   234.28 (-2.42%)
NVDA   465.42 (-0.49%)
NIO   7.07 (-2.75%)
BABA   72.90 (-2.64%)
AMD   119.44 (-1.42%)
T   16.68 (+0.66%)
F   10.44 (+1.75%)
MU   76.03 (-0.12%)
CGC   0.56 (+0.34%)
GE   122.89 (+0.89%)
DIS   92.22 (-0.51%)
AMC   6.80 (+2.26%)
PFE   28.99 (-4.86%)
PYPL   58.28 (+1.16%)
XOM   103.69 (+0.92%)
S&P 500   4,561.76 (-0.13%)
DOW   35,972.66 (+0.06%)
QQQ   387.18 (-0.42%)
AAPL   190.27 (+0.17%)
MSFT   372.29 (-1.75%)
META   321.18 (-1.82%)
GOOGL   130.86 (-1.26%)
AMZN   146.09 (+0.00%)
TSLA   234.28 (-2.42%)
NVDA   465.42 (-0.49%)
NIO   7.07 (-2.75%)
BABA   72.90 (-2.64%)
AMD   119.44 (-1.42%)
T   16.68 (+0.66%)
F   10.44 (+1.75%)
MU   76.03 (-0.12%)
CGC   0.56 (+0.34%)
GE   122.89 (+0.89%)
DIS   92.22 (-0.51%)
AMC   6.80 (+2.26%)
PFE   28.99 (-4.86%)
PYPL   58.28 (+1.16%)
XOM   103.69 (+0.92%)
S&P 500   4,561.76 (-0.13%)
DOW   35,972.66 (+0.06%)
QQQ   387.18 (-0.42%)
AAPL   190.27 (+0.17%)
MSFT   372.29 (-1.75%)
META   321.18 (-1.82%)
GOOGL   130.86 (-1.26%)
AMZN   146.09 (+0.00%)
TSLA   234.28 (-2.42%)
NVDA   465.42 (-0.49%)
NIO   7.07 (-2.75%)
BABA   72.90 (-2.64%)
AMD   119.44 (-1.42%)
T   16.68 (+0.66%)
F   10.44 (+1.75%)
MU   76.03 (-0.12%)
CGC   0.56 (+0.34%)
GE   122.89 (+0.89%)
DIS   92.22 (-0.51%)
AMC   6.80 (+2.26%)
PFE   28.99 (-4.86%)
PYPL   58.28 (+1.16%)
XOM   103.69 (+0.92%)

Inspire Medical Systems Stock Price, News & Analysis (NYSE:INSP)

$145.43
+0.12 (+0.08%)
(As of 10:47 AM ET)
Compare
Today's Range
$143.29
$145.96
50-Day Range
$125.26
$200.61
52-Week Range
$123.27
$330.00
Volume
34,056 shs
Average Volume
491,516 shs
Market Capitalization
$4.29 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$283.92

Inspire Medical Systems MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.85 Rating Score
Upside/​Downside
95.4% Upside
$283.92 Price Target
Short Interest
Healthy
4.47% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.66
Upright™ Environmental Score
News Sentiment
0.40mentions of Inspire Medical Systems in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.48) to ($0.70) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.59 out of 5 stars

Medical Sector

154th out of 948 stocks

Surgical & Medical Instruments Industry

23rd out of 97 stocks


INSP stock logo

About Inspire Medical Systems Stock (NYSE:INSP)

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

INSP Stock Price History

INSP Stock News Headlines

3 Reasons to Retain Inspire Medical (INSP) Stock for Now
Inspire Medical Systems: Time To Wake Up
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
6 Analysts Have This to Say About Inspire Medical Systems
See More Headlines
Receive INSP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inspire Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/07/2023
Today
12/01/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/06/2024

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
755
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$283.92
High Stock Price Target
$371.00
Low Stock Price Target
$159.00
Potential Upside/Downside
+95.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.85
Research Coverage
13 Analysts

Profitability

Net Income
$-44,880,000.00
Pretax Margin
-5.59%

Debt

Sales & Book Value

Annual Sales
$407.86 million
Book Value
$18.43 per share

Miscellaneous

Free Float
28,195,000
Market Cap
$4.29 billion
Optionable
Optionable
Beta
1.48
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report














INSP Stock Analysis - Frequently Asked Questions

Should I buy or sell Inspire Medical Systems stock right now?

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last twelve months. There are currently 2 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" INSP shares.
View INSP analyst ratings
or view top-rated stocks.

What is Inspire Medical Systems' stock price target for 2024?

13 Wall Street analysts have issued 1 year price objectives for Inspire Medical Systems' shares. Their INSP share price targets range from $159.00 to $371.00. On average, they expect the company's share price to reach $283.92 in the next year. This suggests a possible upside of 95.4% from the stock's current price.
View analysts price targets for INSP
or view top-rated stocks among Wall Street analysts.

How have INSP shares performed in 2023?

Inspire Medical Systems' stock was trading at $251.88 at the start of the year. Since then, INSP shares have decreased by 42.3% and is now trading at $145.33.
View the best growth stocks for 2023 here
.

Are investors shorting Inspire Medical Systems?

Inspire Medical Systems saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 1,320,000 shares, an increase of 10.0% from the October 31st total of 1,200,000 shares. Based on an average daily volume of 730,800 shares, the days-to-cover ratio is currently 1.8 days.
View Inspire Medical Systems' Short Interest
.

When is Inspire Medical Systems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 6th 2024.
View our INSP earnings forecast
.

How were Inspire Medical Systems' earnings last quarter?

Inspire Medical Systems, Inc. (NYSE:INSP) released its quarterly earnings data on Tuesday, November, 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.53) by $0.24. The company earned $153.30 million during the quarter, compared to the consensus estimate of $154.49 million. Inspire Medical Systems had a negative net margin of 5.75% and a negative trailing twelve-month return on equity of 6.32%. The business's quarterly revenue was up 40.4% compared to the same quarter last year. During the same quarter last year, the business posted ($0.60) earnings per share.

What is Tim Herbert's approval rating as Inspire Medical Systems' CEO?

2 employees have rated Inspire Medical Systems Chief Executive Officer Tim Herbert on Glassdoor.com. Tim Herbert has an approval rating of 100% among the company's employees. This puts Tim Herbert in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Inspire Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inspire Medical Systems investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Cisco Systems (CSCO), Bank of America (BAC), DocuSign (DOCU), Pfizer (PFE), Block (SQ), Zynga (ZNGA), CrowdStrike (CRWD) and Johnson & Johnson (JNJ).

When did Inspire Medical Systems IPO?

(INSP) raised $75 million in an IPO on Thursday, May 3rd 2018. The company issued 5,000,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs acted as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.

Who are Inspire Medical Systems' major shareholders?

Inspire Medical Systems' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include FMR LLC (8.37%), Westfield Capital Management Co. LP (2.48%), William Blair Investment Management LLC (2.37%), Federated Hermes Inc. (1.68%), Fred Alger Management LLC (1.37%) and Bank of New York Mellon Corp (1.27%). Insiders that own company stock include Georgia Melenikiotou, Jerry C Griffin, John Rondoni, Marilyn C Nelson, Philip Ebeling, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert.
View institutional ownership trends
.

How do I buy shares of Inspire Medical Systems?

Shares of INSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:INSP) was last updated on 12/1/2023 by MarketBeat.com Staff

My Account -